A new effort is underway to legalize not just medical marijuana but recreational use, too. But is that the best route forward ...

A new study shows risks for premature death associated with CUD. Others show increased memory problems, CUD, depression, ...

Kennedy's HHS appointment, Trump's DEA pick, new fast-track meds, and global cannabis trends—this week reshapes the future of ...

“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...

Cannabis use disorder requiring hospital-based care is linked to an increased risk for premature death in a new cohort study.

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

A new cohort study found that schizophrenia cases related to cannabis use disorder serious enough to warrant a person to seek emergency care increased afte ...

The Food and Drug Administration (FDA) has granted Fast Track designation to PP-01 (nabilone/gabapentin) for the mitigation of cannabis withdrawal ...

The incidence of cannabis use disorder associated with schizophrenia almost tripled among Canadian teenagers and adults after ...

Although surveys have found that few clinicians discuss cannabis use with their patients, experts make the case why they ...

From 2014 to 2022, the number of psychiatrists billing Medicare Part B declined, while the total number of active ...

A new study suggests that people who visit the emergency department (ED) due to cannabis use may have a much higher risk of developing anxiety disorders. Within three years, 27% of these individuals ...